Piper Sandler Reiterates Overweight Rating on Arrowhead Pharma (ARWR)
Go back to Piper Sandler Reiterates Overweight Rating on Arrowhead Pharma (ARWR)| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 81.30 +1.40 (1.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $79.90 | 52 Week High | $8.22 | |||
| Open | $80.72 | 52 Week Low | $3.07 | |||
| Day High | $82.84 | P/E | N/A | |||
| Day Low | $80.68 | EPS | $-1.30 | |||
| Volume | 894,956 | |||||
